243 related articles for article (PubMed ID: 17996253)
1. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
[TBL] [Abstract][Full Text] [Related]
3. Combination of nucleoside analogues tiazofurin and ribavirin downregulates experimental autoimmune encephalomyelitis.
Lavrnja I; Stojkov D; Peković S; Subasic S; Mostarica-Stojković M; Stosic-Grujicić S; Nedeljković N; Medic-Mijacević L; Rakić L; Stojiljkovi M
Ann N Y Acad Sci; 2005 Jun; 1048():392-5. PubMed ID: 16154960
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
5. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
Brini E; Ruffini F; Bergami A; Brambilla E; Dati G; Greco B; Cirillo R; Proudfoot AE; Comi G; Furlan R; Zaratin P; Martino G
J Neuroimmunol; 2009 Apr; 209(1-2):33-9. PubMed ID: 19232440
[TBL] [Abstract][Full Text] [Related]
6. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
7. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
[TBL] [Abstract][Full Text] [Related]
8. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
Guo X; Nakamura K; Kohyama K; Harada C; Behanna HA; Watterson DM; Matsumoto Y; Harada T
Neurosci Res; 2007 Dec; 59(4):457-66. PubMed ID: 17920148
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production.
Lavrnja I; Stojkov D; Bjelobaba I; Pekovic S; Dacic S; Nedeljkovic N; Mostarica-Stojkovic M; Stosic-Grujicic S; Rakic L; Stojiljkovic M
Int Immunopharmacol; 2008 Sep; 8(9):1282-90. PubMed ID: 18602075
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
[TBL] [Abstract][Full Text] [Related]
12. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
[TBL] [Abstract][Full Text] [Related]
13. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin.
Stosic-Grujicic S; Savic-Radojevic A; Maksimovic-Ivanic D; Markovic M; Bumbasirevic V; Ramic Z; Mostarica-Stojkovic M
J Neuroimmunol; 2002 Sep; 130(1-2):66-77. PubMed ID: 12225889
[TBL] [Abstract][Full Text] [Related]
15. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
[TBL] [Abstract][Full Text] [Related]
17. A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis.
Hassen GW; Feliberti J; Kesner L; Stracher A; Mokhtarian F
J Neuroimmunol; 2006 Nov; 180(1-2):135-46. PubMed ID: 17007940
[TBL] [Abstract][Full Text] [Related]
18. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.
Almolda B; Costa M; Montoya M; González B; Castellano B
J Neuroimmunol; 2009 Apr; 209(1-2):65-80. PubMed ID: 19246105
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins.
Mohamed A; Reid PF; Raymond L; Dufan T
Biomed Sci Instrum; 2006; 42():399-404. PubMed ID: 16817641
[TBL] [Abstract][Full Text] [Related]
20. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
